Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00041"
Predicate | Value (sorted: none) |
---|---|
ns1:interactsWith | |
rdf:type | |
owl:sameAs | |
owl:sameAs | |
ns1:interactsWith | |
ns1:drugCategory | |
ns1:interactsWith | |
rdfs:label |
"Aldesleukin"
|
owl:sameAs | |
owl:sameAs | |
ns1:drugCategory | |
owl:sameAs | |
ns1:description |
"Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal alanine; the codon for this amino acid was deleted during the genetic engineering procedure; c) the molecule has serine substituted for cysteine at amino acid position 125."
|
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt
The resource appears as object in 6 triples